Sinclair Dunlop

Insider Reports History

Entity
Individual
Location
C/O Apellis Pharmaceuticals, Inc., 6400 Westwind Way, Suite A, Crestwood, KY
Signature
/s/ David Watson, attorney-in-fact for Sinclair Dunlop
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sinclair Dunlop:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 152K $2.01M $13.19 Sep 23, 2024 Direct
Apellis Pharmaceuticals, Inc. Director Common Stock 100K $1.32M $13.19 Sep 23, 2024 Indirect Owner (Epidarex)
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $66.30 Sep 23, 2024 Direct

Insider Reports Filed by Sinclair Dunlop

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Sep 23, 2024 2 $60.7K 4 Sep 24, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Sep 16, 2024 2 -$1.34M 4 Sep 17, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Jun 28, 2024 2 $11.9K 4 Jul 1, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Jun 21, 2024 2 -$1.45M 4 Jun 21, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Apr 12, 2024 2 $19.8K 4 Apr 15, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Mar 19, 2024 1 -$1.07M 4 Mar 20, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2024 2 $344K 4 Jan 2, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Dec 14, 2023 2 $82.8K 4 Dec 15, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Dec 1, 2023 1 -$1.47M 4 Dec 5, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Nov 17, 2023 1 -$445K 4 Nov 21, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Nov 17, 2023 1 -$1.18M 4 Nov 21, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Apr 3, 2023 1 -$37K 4 Apr 5, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Mar 1, 2023 1 -$32.7K 4 Mar 2, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Feb 1, 2023 1 -$26.3K 4 Feb 2, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Jan 3, 2023 1 -$25.4K 4 Jan 5, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Dec 1, 2022 1 -$25K 4 Dec 2, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Nov 1, 2022 1 -$30.4K 4 Nov 3, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Sep 8, 2022 1 -$975K 4 Sep 8, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Aug 25, 2022 2 $56.8K 4 Aug 26, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Aug 16, 2022 2 $356K 4 Aug 17, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Aug 11, 2022 1 -$1.97M 4 Aug 12, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Jul 21, 2022 2 $134K 4 Jul 22, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Jun 27, 2022 1 -$62.7K 4 Jun 29, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Jun 23, 2022 1 -$675K 4 Jun 24, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Apr 22, 2022 2 $280K 4 Apr 25, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2022 2 $0 4 Jan 4, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Sep 10, 2021 2 $96.5K 4 Sep 13, 2021 Director
APLS Apellis Pharmaceuticals, Inc. Jun 1, 2021 3 $0 4 Jun 2, 2021 Director
APLS Apellis Pharmaceuticals, Inc. May 18, 2021 9 -$8.56M 4 May 20, 2021 Director